Drugs / MPH
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04283604 | May 2021 → Mar 2024 | attention deficit-hyperactivity disorder | Loewenstein Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MPH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04283604 ↗ |
| Route | Oral | “he/she will consume their own prescribed MPH by them self.” NCT04283604 ↗ |